Cargando…
Aryl Fluorosulfate Based Inhibitors That Covalently Target the SIRT5 Lysine Deacylase
The sirtuin enzymes are a family of lysine deacylases that regulate gene transcription and metabolism. Sirtuin 5 (SIRT5) hydrolyzes malonyl, succinyl, and glutaryl ϵ‐N‐carboxyacyllysine posttranslational modifications and has recently emerged as a vulnerability in certain cancers. However, chemical...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828517/ https://www.ncbi.nlm.nih.gov/pubmed/36130196 http://dx.doi.org/10.1002/anie.202204565 |
_version_ | 1784867291400241152 |
---|---|
author | Bolding, Julie E. Martín‐Gago, Pablo Rajabi, Nima Gamon, Luke F. Hansen, Tobias N. Bartling, Christian R. O. Strømgaard, Kristian Davies, Michael J. Olsen, Christian A. |
author_facet | Bolding, Julie E. Martín‐Gago, Pablo Rajabi, Nima Gamon, Luke F. Hansen, Tobias N. Bartling, Christian R. O. Strømgaard, Kristian Davies, Michael J. Olsen, Christian A. |
author_sort | Bolding, Julie E. |
collection | PubMed |
description | The sirtuin enzymes are a family of lysine deacylases that regulate gene transcription and metabolism. Sirtuin 5 (SIRT5) hydrolyzes malonyl, succinyl, and glutaryl ϵ‐N‐carboxyacyllysine posttranslational modifications and has recently emerged as a vulnerability in certain cancers. However, chemical probes to illuminate its potential as a pharmacological target have been lacking. Here we report the harnessing of aryl fluorosulfate‐based electrophiles as an avenue to furnish covalent inhibitors that target SIRT5. Alkyne‐tagged affinity‐labeling agents recognize and capture overexpressed SIRT5 in cultured HEK293T cells and can label SIRT5 in the hearts of mice upon intravenous injection of the compound. This work demonstrates the utility of aryl fluorosulfate electrophiles for targeting of SIRT5 and suggests this as a means for the development of potential covalent drug candidates. It is our hope that these results will serve as inspiration for future studies investigating SIRT5 and general sirtuin biology in the mitochondria. |
format | Online Article Text |
id | pubmed-9828517 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98285172023-01-10 Aryl Fluorosulfate Based Inhibitors That Covalently Target the SIRT5 Lysine Deacylase Bolding, Julie E. Martín‐Gago, Pablo Rajabi, Nima Gamon, Luke F. Hansen, Tobias N. Bartling, Christian R. O. Strømgaard, Kristian Davies, Michael J. Olsen, Christian A. Angew Chem Int Ed Engl Research Articles The sirtuin enzymes are a family of lysine deacylases that regulate gene transcription and metabolism. Sirtuin 5 (SIRT5) hydrolyzes malonyl, succinyl, and glutaryl ϵ‐N‐carboxyacyllysine posttranslational modifications and has recently emerged as a vulnerability in certain cancers. However, chemical probes to illuminate its potential as a pharmacological target have been lacking. Here we report the harnessing of aryl fluorosulfate‐based electrophiles as an avenue to furnish covalent inhibitors that target SIRT5. Alkyne‐tagged affinity‐labeling agents recognize and capture overexpressed SIRT5 in cultured HEK293T cells and can label SIRT5 in the hearts of mice upon intravenous injection of the compound. This work demonstrates the utility of aryl fluorosulfate electrophiles for targeting of SIRT5 and suggests this as a means for the development of potential covalent drug candidates. It is our hope that these results will serve as inspiration for future studies investigating SIRT5 and general sirtuin biology in the mitochondria. John Wiley and Sons Inc. 2022-10-21 2022-11-21 /pmc/articles/PMC9828517/ /pubmed/36130196 http://dx.doi.org/10.1002/anie.202204565 Text en © 2022 The Authors. Angewandte Chemie International Edition published by Wiley-VCH GmbH https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Research Articles Bolding, Julie E. Martín‐Gago, Pablo Rajabi, Nima Gamon, Luke F. Hansen, Tobias N. Bartling, Christian R. O. Strømgaard, Kristian Davies, Michael J. Olsen, Christian A. Aryl Fluorosulfate Based Inhibitors That Covalently Target the SIRT5 Lysine Deacylase |
title | Aryl Fluorosulfate Based Inhibitors That Covalently Target the SIRT5 Lysine Deacylase
|
title_full | Aryl Fluorosulfate Based Inhibitors That Covalently Target the SIRT5 Lysine Deacylase
|
title_fullStr | Aryl Fluorosulfate Based Inhibitors That Covalently Target the SIRT5 Lysine Deacylase
|
title_full_unstemmed | Aryl Fluorosulfate Based Inhibitors That Covalently Target the SIRT5 Lysine Deacylase
|
title_short | Aryl Fluorosulfate Based Inhibitors That Covalently Target the SIRT5 Lysine Deacylase
|
title_sort | aryl fluorosulfate based inhibitors that covalently target the sirt5 lysine deacylase |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828517/ https://www.ncbi.nlm.nih.gov/pubmed/36130196 http://dx.doi.org/10.1002/anie.202204565 |
work_keys_str_mv | AT boldingjuliee arylfluorosulfatebasedinhibitorsthatcovalentlytargetthesirt5lysinedeacylase AT martingagopablo arylfluorosulfatebasedinhibitorsthatcovalentlytargetthesirt5lysinedeacylase AT rajabinima arylfluorosulfatebasedinhibitorsthatcovalentlytargetthesirt5lysinedeacylase AT gamonlukef arylfluorosulfatebasedinhibitorsthatcovalentlytargetthesirt5lysinedeacylase AT hansentobiasn arylfluorosulfatebasedinhibitorsthatcovalentlytargetthesirt5lysinedeacylase AT bartlingchristianro arylfluorosulfatebasedinhibitorsthatcovalentlytargetthesirt5lysinedeacylase AT strømgaardkristian arylfluorosulfatebasedinhibitorsthatcovalentlytargetthesirt5lysinedeacylase AT daviesmichaelj arylfluorosulfatebasedinhibitorsthatcovalentlytargetthesirt5lysinedeacylase AT olsenchristiana arylfluorosulfatebasedinhibitorsthatcovalentlytargetthesirt5lysinedeacylase |